Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. 1985

G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry

The prevalence of antibodies detected by ELISA against human T-lymphotropic viruses, type I (HTLV-I) and type III (HTLV-III-LAV), is described in a comparative serosurvey in the French West Indies and African countries. The data confirm that the Caribbean basin is endemic for HTLV-I. In this region, HTLV-I antibody prevalence varied from 3.4% to 5.2% among blood donors and increased with age to reach a value of 33% among elderly people from the Dominica Island. In French Guyana, a South American country bordering the Caribbean sea, differences in antibody distribution across three ethnic groups (black Bonis, Indian Wayanas, and Hmongs from Asia) provide clues for investigation of the mode of HTLV-I transmission. Africa appears to be an endemic continent for HTLV-I and HTLV-III. For both viruses, the antibody prevalence exhibited an increasing gradient from northern to equatorial through Sudanic areas. These preliminary data by showing that Africa represents an endemic reservoir of HTLVs and, possibly, of other human retroviruses should stimulate further investigations on the natural history and the geographical origin of these viruses.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005006 Ethnicity A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnic Groups,Nationality,Ethnic Group,Nationalities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000349 Africa The continent south of EUROPE, east of the ATLANTIC OCEAN and west of the INDIAN OCEAN.

Related Publications

G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
March 1991, European journal of epidemiology,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
December 1989, European journal of epidemiology,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
February 1992, The Journal of infectious diseases,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
July 1989, Clinical and experimental immunology,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
March 2000, Tropical medicine & international health : TM & IH,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
June 2008, Virologie (Montrouge, France),
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
May 1958, Publication. Cayenne, French Guiana. Institut Pasteur de la Guyane francaise et de l'Inini,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
September 2013, Journal of neurological surgery. Part A, Central European neurosurgery,
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
December 1982, Lancet (London, England),
G de-Thé, and A Gessain, and L Gazzolo, and M Robert-Guroff, and G Najberg, and A Calender, and M Peti, and G Brubaker, and A Bensliman, and F Fabry
January 1992, Bulletin de la Societe de pathologie exotique (1990),
Copied contents to your clipboard!